← FDA Drug Approvals (Drugs@FDA)

VASOPRESSIN

NDA · New Drug Application · Sponsor: AM REGENT · Approved 2020-08-03

Drug application

FDA Application #
NDA212593
Application type
New Drug Application
Brand name
VASOPRESSIN
Generic name
VASOPRESSIN
Active ingredients
VASOPRESSIN
Dosage form
SOLUTION
Route
INTRAVENOUS
Marketing status
Prescription
Sponsor
AM REGENT
Manufacturer
Civica, Inc.
First approval
2020-08-03

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown